Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software
NCT ID: NCT04980989
Last Updated: 2021-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
765 participants
INTERVENTIONAL
2015-06-15
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834
The Digital Breast Tomosynthesis Trial in Bergen
NCT02835625
Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer
NCT07344597
Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
NCT04967209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary end point was to find out patient preference for the modality of surveillance. Secondary endpoints were patient satisfaction, symptoms, quality of life and cost of follow-up during surveillance modalities.
At 12 months the patients were asked their preference for the follow-up modality of early breast cancer. At baseline, 6 months and 12 months the patients answered the other questionnaires on quality of life, symptoms, patient satisfaction and use of other health-care services. Information on the cost of follow-up was gathered from the hospital and other registries.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mobile software
Patient with early breast cancer were followed-up by mobile software for the first six months. At six months they crossed-over to be followed-up by telephone calls for the next six months.
Mobile software for follow-up of early breast cancer
The patients were randomized to use mobile software or telephone calls as the follow-up modality for early breast cancer
Telephone calls
Patient with early breast cancer were followed-up by telephone calls for the first six months. At six months they crossed-over to be followed-up by mobile software for the next six months.
Mobile software for follow-up of early breast cancer
The patients were randomized to use mobile software or telephone calls as the follow-up modality for early breast cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile software for follow-up of early breast cancer
The patients were randomized to use mobile software or telephone calls as the follow-up modality for early breast cancer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* another malignancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Helsinki
OTHER
Noona Healthcare
UNKNOWN
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johanna Mattson
Physician-in-Chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johanna Mattson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Helsinki University Central Hospital
Carl Blomqvist, Professor
Role: STUDY_CHAIR
Helsinki University Central Hospital
Johanna Mattson, MD, PhD
Role: STUDY_DIRECTOR
Helsinki University Central Hospital
References
Explore related publications, articles, or registry entries linked to this study.
Mattson J, Peltola M, Poikonen-Saksela P, Hermanson T, Their J, Farkkila N, Roine R, Blomqvist C. Digital solution in the follow-up of early breast cancer a randomized study. Acta Oncol. 2023 May;62(5):513-521. doi: 10.1080/0284186X.2023.2212409. Epub 2023 May 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
112/13/03/02/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.